Effective Treatment with Revugam 25mg Tablet

Revugam 25mg Tablet

Uses:

• Treatment of low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
• Treatment of severe aplastic anaemia.

Mechanism of action:

• Stimulates megakaryocytes (large bone marrow cells) responsible for producing platelets.
• Raises the number of platelets in the blood, preventing bleeding and bruising.

Important information:

• Contraindicated in individuals with hypersensitivity to the drug or its components.
• Not recommended for patients with severe liver impairment or active liver disease.
• Caution advised in patients with severe liver disease.
• Regular monitoring of platelet count and other blood parameters required.
• High platelet count can increase the risk of blood clotting.
• Avoid dairy products, antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminum, selenium, and zinc) within 2 hours before or 4 hours after taking the medication.
• Effective birth control during treatment.
• Not advised for children under one with ITP, and not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anaemia.

Side effects:

• Nausea.
• Diarrhea, abdominal pain.
• Common cold.
• Cough.
• Respiratory tract infection.
• Back pain.
• High temperature.
• Loss of appetite.
• Hair loss.
• Swelling in feet or hands.
• Headache, dizziness.
• Mouth and throat pain.
• Joint pain.

Safety advice:

• Pregnancy: not recommended due to potential fetal harm.
• Breastfeeding: consult a doctor.
• Lungs: consult a doctor if you have lung diseases.
• Liver: dose adjustments necessary for severe liver failure.
• Alcohol: consult a doctor if you drink alcoholic beverages.
• Driving: avoid driving vehicles or operating heavy machinery.

FAQ:

1. What is ITP?
   • Immune thrombocytopenia (ITP) is a rare blood disorder characterized by insufficient platelets in the blood, which can cause bruising and bleeding.
2. Who should not use the Revugam 25mg Tablet?
   • People with ITP, children under one, and individuals with severe aplastic anemia and hepatitis C should not use the Revugam 25mg Tablet.
3. Will you be monitored during treatment with the Revugam 25mg Tablet?
   • Yes, regular monitoring of white blood cell count, platelets, blood clotting factors, heart rate, eye tests, and complete blood count is required.
4. Is it safe to take a Revugam 25mg Tablet on an empty stomach?
   • Yes, the Revugam 25mg Tablet should be taken on an empty stomach to avoid interference with absorption from dairy products, antacids, and mineral and vitamin supplements.
5. What happens if you discontinue using the Revugam 25mg Tablet?
   • Discontinuing the Revugam 25mg Tablet suddenly can lead to a decrease in platelet count and severe bleeding. Consult your healthcare practitioner before discontinuing the medication.
6. How to store a Revugam 25mg Tablet?
   • Store at room temperature (25°C) and out of reach of children. Do not use after the expiration date.

Fact box:

• Molecule name: Eltrombopag.
• Therapeutic class: Anticoagulant.
• Pharmacological class: Thrombopoietin (TPO) receptor agonist.

Tags: medical-drug, tablet, revugam, 25mg, pharmaceutical, healthcare